Affiliations
AffiliationsItem in Clipboard
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 casesAndrew William Byrne et al. BMJ Open. 2020.
. 2020 Aug 5;10(8):e039856. doi: 10.1136/bmjopen-2020-039856. Authors Andrew William Byrne 1 , David McEvoy 2 , Aine B Collins 3 4 , Kevin Hunt 5 , Miriam Casey 3 , Ann Barber 3 , Francis Butler 5 , John Griffin 4 , Elizabeth A Lane 3 4 , Conor McAloon 6 , Kirsty O'Brien 7 , Patrick Wall 8 , Kieran A Walsh 7 , Simon J More 3 AffiliationsItem in Clipboard
AbstractObjectives: Our objective was to review the literature on the inferred duration of the infectious period of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, and provide an overview of the variation depending on the methodological approach.
Design: Rapid scoping review. Literature review with fixed search terms, up to 1 April 2020. Central tendency and variation of the parameter estimates for infectious period in (A) asymptomatic and (B) symptomatic cases from (1) virological studies (repeated testing), (2) tracing studies and (3) modelling studies were gathered. Narrative review of viral dynamics.
Information sources: Search strategies developed and the following searched: PubMed, Google Scholar, MedRxiv and BioRxiv. Additionally, the Health Information Quality Authority (Ireland) viral load synthesis was used, which screened literature from PubMed, Embase, ScienceDirect, NHS evidence, Cochrane, medRxiv and bioRxiv, and HRB open databases.
Results: There was substantial variation in the estimates, and how infectious period was inferred. One study provided approximate median infectious period for asymptomatic cases of 6.5-9.5 days. Median presymptomatic infectious period across studies varied over <1-4 days. Estimated mean time from symptom onset to two negative RT-PCR tests was 13.4 days (95% CI 10.9 to 15.8) but was shorter when studies included children or less severe cases. Estimated mean duration from symptom onset to hospital discharge or death (potential maximal infectious period) was 18.1 days (95% CI 15.1 to 21.0); time to discharge was on average 4 days shorter than time to death. Viral dynamic data and model infectious parameters were often shorter than repeated diagnostic data.
Conclusions: There are limitations of inferring infectiousness from repeated diagnosis, viral loads and viral replication data alone and also potential patient recall bias relevant to estimating exposure and symptom onset times. Despite this, available data provide a preliminary evidence base to inform models of central tendency for key parameters and variation for exploring parameter space and sensitivity analysis.
Keywords: epidemiology; infectious diseases; public health; virology.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statementCompeting interests: None declared.
FiguresFigure 1
Simulation of the parameter distribution…
Figure 1
Simulation of the parameter distribution inferred for duration of infectious period for asymptomatic…
Figure 1Simulation of the parameter distribution inferred for duration of infectious period for asymptomatic cases (T2); inferred infectious period for Davies et al, grey/blue curve, Davies et al pink curve (model priors). Green curve: Ma et al. Histogram is the distribution of asymptomatic cases to two clear tests reported by Hu et al. Reference lines are point estimates reported from Zhou et al, Li et al and Tuite et al.
Figure 2
Simulation of the parameter distribution…
Figure 2
Simulation of the parameter distribution used for T3 (the duration of the pre-symptomatic…
Figure 2Simulation of the parameter distribution used for T3 (the duration of the pre-symptomatic infectious period for those infected individuals who subsequently develop symptoms). Curves represent simulated approximations of distributions, given information provided from primary literature. Vertical lines represent point estimates where distributions could not be inferred (see table 2). 1. Peak et al (posterior); 2. Davies et al(prior); 3. Rothe et al; 4. He et al; 5. Davies et al (prior); 6. Wei et al.
Figure 3
Forest plot of the mean…
Figure 3
Forest plot of the mean duration from onset of symptoms to death or…
Figure 3Forest plot of the mean duration from onset of symptoms to death or recovery (T5) based on virological studies.
Figure 4
Frequency distribution of T5, time…
Figure 4
Frequency distribution of T5, time from onset of symptoms to recovery (here hospital…
Figure 4Frequency distribution of T5, time from onset of symptoms to recovery (here hospital discharge or death), using patient level raw data from Kraemer et al (pink bars), Linton et al (purple bars) and Tindale et al (green bars). Blue solid line is the kernel density of the aggregated dataset. Dashed lines represent the mean and 95% CI from a random effects regression model.
Figure 5
Composite inferred model for cycle…
Figure 5
Composite inferred model for cycle threshold (CT) value changes from serial RT-PCR testing…
Figure 5Composite inferred model for cycle threshold (CT) value changes from serial RT-PCR testing for SARS-CoV-2; currently uncertain whether peak viral load typically occurs prior to, on or postsymptom onset (primary literature informing this model includes. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Similar articlesFox T, Geppert J, Dinnes J, Scandrett K, Bigio J, Sulis G, Hettiarachchi D, Mathangasinghe Y, Weeratunga P, Wickramasinghe D, Bergman H, Buckley BS, Probyn K, Sguassero Y, Davenport C, Cunningham J, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Struyf T, Van den Bruel A, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Deeks JJ; Cochrane COVID-19 Diagnostic Test Accuracy Group. Fox T, et al. Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article. Review.
Elwenspoek MM, Thom H, Sheppard AL, Keeney E, O'Donnell R, Jackson J, Roadevin C, Dawson S, Lane D, Stubbs J, Everitt H, Watson JC, Hay AD, Gillett P, Robins G, Jones HE, Mallett S, Whiting PF. Elwenspoek MM, et al. Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371. Health Technol Assess. 2022. PMID: 36321689 Free PMC article.
Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, Røsjø H, Dalgard O. Lyngbakken MN, et al. Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0. Trials. 2020. PMID: 32503662 Free PMC article.
de Leeuw RA, Burger NB, Ceccaroni M, Zhang J, Tuynman J, Mabrouk M, Barri Soldevila P, Bonjer HJ, Ankum P, Huirne J. de Leeuw RA, et al. JMIR Public Health Surveill. 2020 Jun 23;6(2):e18928. doi: 10.2196/18928. JMIR Public Health Surveill. 2020. PMID: 32406853 Free PMC article.
Watanabe A, Matsuda H. Watanabe A, et al. Health Care Manag Sci. 2023 Mar;26(1):46-61. doi: 10.1007/s10729-022-09617-0. Epub 2022 Oct 6. Health Care Manag Sci. 2023. PMID: 36203115 Free PMC article.
Engelmann I, Alidjinou EK, Ogiez J, Pagneux Q, Miloudi S, Benhalima I, Ouafi M, Sane F, Hober D, Roussel A, Cambillau C, Devos D, Boukherroub R, Szunerits S. Engelmann I, et al. ACS Omega. 2021 Mar 6;6(10):6528-6536. doi: 10.1021/acsomega.1c00166. eCollection 2021 Mar 16. ACS Omega. 2021. PMID: 33748564 Free PMC article. Review.
Kim D, Keskinocak P, Pekgün P, Yildirim İ. Kim D, et al. Sci Rep. 2022 May 6;12(1):7493. doi: 10.1038/s41598-022-11060-8. Sci Rep. 2022. PMID: 35523832 Free PMC article.
Sánchez CA, Li H, Phelps KL, Zambrana-Torrelio C, Wang LF, Zhou P, Shi ZL, Olival KJ, Daszak P. Sánchez CA, et al. Nat Commun. 2022 Aug 9;13(1):4380. doi: 10.1038/s41467-022-31860-w. Nat Commun. 2022. PMID: 35945197 Free PMC article.
Mabuka T, Ncube N, Ross M, Silaji A, Macharia W, Ndemera T, Lemeke T. Mabuka T, et al. BMC Public Health. 2023 Aug 5;23(1):1492. doi: 10.1186/s12889-023-16162-0. BMC Public Health. 2023. PMID: 37542267 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3